 |
|
|
| |
In F0-F1 and F2-F3 MASH, ≥ 5% weight loss significantly lowers VCTE and ELFTM independent of biopsy fibrosis improvement; resmetirom and not placebo reduction of ELF and VCTE are associated with biopsy improvement of fibrosis, independent of weight loss
|
| |
| |
Rohit Loomba1, Quentin M. Anstee2, Rebecca Taub3, Dominic Labriola3, Robin Mogg3, Suneil Hosmane3, Jorn M. Schattenberg4, Vlad Ratziu
|
| |
|
|
|
|
|
